UNSPSC 51286401: Octapinol

This classification denotes an antimicrobial with the molecular formula C15H31NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4758KDH62A, chemically known as 1-piperidineethanol, 4-(2-procylpentyl)- but more generally known as octapinol, which bears US NIH Compound Identifier 68906. European Medicines Agency schedules Octapinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09406MIG.

The term OCTAPINOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 34, No. 10 1980, List 20). OCTAPINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OCCN1CCC(CC(CCC)CCC)CC1.

UNSPSC 51286401 Octapinol is a Commodity code that nominally classifies a specific pharmaceutical active ingredient, but the recent state and local procurement record shows no solicitations for octapinol itself. The two opportunities tagged under this code involve unrelated pharmaceutical products: one is a completed piggyback award for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and the other is an open bid for naloxone and drug deactivation systems. Neither opportunity involves octapinol procurement. State and local health departments and counties appear to use this code for pharmaceutical supply contracts when vendors or procurement systems default to it, but the mismatch between the code's scope and the actual work being solicited suggests either inconsistent tagging or limited recent activity under the intended commodity classification.

The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (closed award, not open). Seminole County, Florida released an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford; the bid deadline was July 26, 2023. Activity under this code appears concentrated in Florida and Illinois, though the tagging inconsistency and the absence of octapinol-specific solicitations suggest limited market activity. Firms pursuing state and local pharmaceutical procurement should monitor this code cautiously and verify actual commodity requirements in RFP and IFB documents, as the Commodity classification may not reflect what is actually being solicited.